|
|
|
Volumn 38, Issue 1, 1997, Pages 33-40
|
|
The detection of minimal residual disease by DEK/CAN chimeric m-RNA in a case of AML M2 with translocation t(6;9) (p23;q34) after chemotherapy and peripheral blood stem cell transplantation
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
BH AC DMP PROTOCOL;
BH-AC-DMP PROTOCOL;
CYTARABINE;
DAUNORUBICIN;
DEK CAN FUSION PROTEIN, RECOMBINANT;
DEK-CAN FUSION PROTEIN, RECOMBINANT;
DRUG DERIVATIVE;
ETOPOSIDE;
HYBRID PROTEIN;
MAV PROTOCOL;
MERCAPTOPURINE;
MESSENGER RNA;
MITOXANTRONE;
ONCOPROTEIN;
PREDNISOLONE;
ACUTE GRANULOCYTIC LEUKEMIA;
ADOLESCENT;
ARTICLE;
CASE REPORT;
CHROMOSOME 6;
CHROMOSOME 9;
FEMALE;
GENE TRANSLOCATION;
GENETICS;
HEMATOPOIETIC STEM CELL TRANSPLANTATION;
HUMAN;
MINIMAL RESIDUAL DISEASE;
MULTIMODALITY CANCER THERAPY;
POLYMERASE CHAIN REACTION;
6-MERCAPTOPURINE;
ADOLESCENT;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CHROMOSOMES, HUMAN, PAIR 6;
CHROMOSOMES, HUMAN, PAIR 9;
COMBINED MODALITY THERAPY;
CYTARABINE;
DAUNORUBICIN;
ETOPOSIDE;
FEMALE;
HEMATOPOIETIC STEM CELL TRANSPLANTATION;
HUMANS;
LEUKEMIA, MYELOCYTIC, ACUTE;
MITOXANTRONE;
NEOPLASM, RESIDUAL;
ONCOGENE PROTEINS;
ONCOGENE PROTEINS, FUSION;
POLYMERASE CHAIN REACTION;
PREDNISOLONE;
RECOMBINANT FUSION PROTEINS;
RNA, MESSENGER;
TRANSLOCATION, GENETIC;
|
|
EID: 0030638310
PISSN: 04851439
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (3)
|
|
References (0)
|
